Clin2Atlas
AtlasLungs & breathingChronic respiratory diseases

Asthma

2Disease-modifyingAI-generated
Burden-over-time charts — how many people this disease affects and whether that number is rising or falling — are coming to this page. The treatability read, milestones, and live trial pipeline below are current.

Milestones

dot size = significance
199020002010202020251990 — Fluticasone propionate approved (FDA)1994 — Salmeterol approved (FDA)1994 — Budesonide approved (FDA)1996 — Zileuton approved (FDA)1996 — Zafirlukast approved (FDA)1998 — Montelukast approved (FDA)2001 — Formoterol approved (FDA)2003 — Omalizumab approved (FDA)2004 — Tiotropium approved (FDA)2006 — Ciclesonide approved (FDA)2007 — Fluticasone furoate approved (FDA)2008 — Menthol approved (FDA)2013 — Vilanterol approved (FDA)2015 — Mepolizumab approved (FDA)2016 — Ephedrine approved (FDA)2016 — Reslizumab approved (FDA)2017 — Dupilumab approved (FDA)2017 — Benralizumab approved (FDA)2021 — Tezepelumab approved (FDA)2003201520172021
1990: Drug approval — Fluticasone propionate approved (FDA). 1994: Drug approval — Salmeterol approved (FDA). 1994: Drug approval — Budesonide approved (FDA). 1996: Drug approval — Zileuton approved (FDA). 1996: Drug approval — Zafirlukast approved (FDA). 1998: Drug approval — Montelukast approved (FDA). 2001: Drug approval — Formoterol approved (FDA). 2003: Drug approval — Omalizumab approved (FDA). 2004: Drug approval — Tiotropium approved (FDA). 2006: Drug approval — Ciclesonide approved (FDA). 2007: Drug approval — Fluticasone furoate approved (FDA). 2008: Drug approval — Menthol approved (FDA). 2013: Drug approval — Vilanterol approved (FDA). 2015: Drug approval — Mepolizumab approved (FDA). 2016: Drug approval — Ephedrine approved (FDA). 2016: Drug approval — Reslizumab approved (FDA). 2017: Drug approval — Dupilumab approved (FDA). 2017: Drug approval — Benralizumab approved (FDA). 2021: Drug approval — Tezepelumab approved (FDA)

What's being tested now

2007: 2 trials started2008: 1 trials started2010: 5 trials started2011: 5 trials started2012: 6 trials started2013: 5 trials started2014: 3 trials started2015: 5 trials started2016: 2 trials started2017: 8 trials started2018: 5 trials started2019: 12 trials started2020: 8 trials started2021: 21 trials started2022: 28 trials started2023: 46 trials started2024: 114 trials started2025: 113 trials started2026: 125 trials started201020202026125

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

See all 464 active Asthma trials on Clin2 →

Related

Chronic obstructive pulmonary diseaseInterstitial lung disease and pulmonary sarcoidosisOther chronic respiratory diseases

Burden estimates: IHME Global Burden of Disease Study. Drug indications: ChEMBL (CC BY-SA). Trial data: ClinicalTrials.gov via Clin2. Velocity, acceleration, and turning points are computed by Clin2 — how this page is made. Treatability describes what medicine can do, not what is available everywhere. This page describes populations, not people, and is not medical advice.